A novel p21WAF1/CIP1 transcript is highly dependent on p53 for its basal expression in mouse tissues

Oncogene

Volumn 23, Issue 49, 2004, Pages 8154-8157

  Gartel, Andrei L ^a   Radhakrishnan, Senthil K ^a   Serfas, Michael S ^a,b   Kwon, Young H ^a,c   Tyner, Angela L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c Kookmin University   (South Korea)

Author keywords

Alternate transcript; p21; p53

Indexed keywords

PROTEIN P21; PROTEIN P53; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA DAMAGE; EXON; GENE EXPRESSION; GENE IDENTIFICATION; GENE INDUCTION; GENETIC TRANSCRIPTION; GROWTH INHIBITION; MOUSE; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TARGETING; SPLEEN; TEMPERATURE DEPENDENCE; TRANSCRIPTION INITIATION SITE; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; MOLECULAR GENETICS; PHYSIOLOGY;

ANIMALIA;

ANIMALS; BASE SEQUENCE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENE EXPRESSION REGULATION; MICE; MOLECULAR SEQUENCE DATA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 7944226274     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207820     Document Type: Article

References (23)

1. Brugarolas J, Moberg K, Boyd SD, Taya Y, Jacks T and Lees JA. (1999). Proc. Natl. Acad. Sci. USA, 96, 1002-1007.
2. Couronne O, Poliakov A, Bray N, Ishkhanov T, Ryaboy D, Rubin E, Pachter L and Dubchak I. (2003). Genome Res., 13, 73-80.
3. Duro D, Bernard O, Della Valle V, Berger R and Larsen CJ. (1995). Oncogene, 11, 21-29.
4. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
5. el-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, Healy E, Rees JL, Hamilton SR, Kinzler KW and Vogelstein B. (1995). Cancer Res., 55, 2910-2919.
6. Gartel AL, Serfas MS and Tyner AL. (1996). Proc. Soc. Exp. Biol. Med., 213, 138-149.
7. Gartel AL and Tyner AL. (1999). Exp. Cell Res., 246, 280-289.
8. Gribnau J, Diderich K, Pruzina S, Calzolari R and Fraser P. (2000). Mol. Cell, 5, 377-386.
9. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E, Fox MP and Wei N. (1995). Mol. Cell. Biol., 6, 387-400.
10. Hogga I and Karch F. (2002). Development, 129, 4915-4922.
11. Huppi K, Siwarski D, Dosik J, Michieli P, Chedid M, Reed S, Mock B, Givol D and Mushinski JF. (1994). Oncogene, 9, 3017-3020.
12. Landry JR, Mager DL and Wilhelm BT. (2003). Trends Genet., 19, 640-648.
13. Levine M and Tjian R. (2003). Nature, 424, 147-151.
14. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B and Jacks T. (1995). Genes Dev., 9, 935-944.
15. Mao L, Merlo A, Bedi G, Shapiro GI, Edwards CD, Rollins BJ and Sidransky D. (1995). Cancer Res., 55, 2995-2997.
16. Nozell S and Chen X. (2002). Oncogene, 21, 1285-1294.
17. Nunez F, Chipchase MD, Clarke AR and Melton DW. (2000). FASEB J., 14, 1073-1082.
18. Phelps DE, Hsiao KM, Li Y, Hu N, Franklin DS, Westphal E, Lee EY and Xiong Y. (1998). Mol. Cell. Biol., 18, 2334-2343.
19. Quelle DE, Zindy F, Ashmun RA and Sherr CJ. (1995). Cell, 83, 993-1000.
20. Tokino T, Urano T, Furuhata T, Matsushima M, Miyatsu T, Sasaki S and Nakamura Y. (1996). Hum. Genet., 97, 625-631.
21. Tsubari M, Tiihonen E and Laiho M. (1997). Cancer Res., 57, 2966-2973.
22. Wang X and Chamberlin HM. (2004). Nat. Genet., 36, 231-232.
23. Zambetti GP, Bargonetti J, Walker K, Prives C and Levine AJ. (1992). Genes Dev., 6, 1143-1152.